SIMPLEX TRADING, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 57 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$5,000
-96.7%
4,901
-92.8%
0.00%
Q4 2021$153,000
-19.9%
68,269
+6.8%
0.00%
Q3 2021$191,0000.0%63,9110.0%0.00%
Q2 2021$191,000
+7.3%
63,911
+15.4%
0.00%
Q1 2021$178,000
+1171.4%
55,363
+722.1%
0.00%
Q4 2020$14,000
+1300.0%
6,734
+649.1%
0.00%
Q1 2019$1,000
-50.0%
899
-52.1%
0.00%
Q4 2018$2,000
-99.0%
1,876
-97.3%
0.00%
-100.0%
Q3 2018$191,000
+1173.3%
70,516
+796.9%
0.00%
Q2 2018$15,000
-76.2%
7,862
-74.2%
0.00%
-100.0%
Q1 2018$63,000
+10.5%
30,433
+7.0%
0.00%
+50.0%
Q4 2017$57,000
+612.5%
28,445
+320.9%
0.00%
Q3 2017$8,0006,758
+112533.3%
0.00%
Q2 2017$0
-100.0%
6
-99.8%
0.00%
Q4 2016$4,0003,314
+3388.4%
0.00%
Q3 2016$0
-100.0%
95
-93.5%
0.00%
-100.0%
Q3 2015$12,000
-36.8%
1,462
-17.3%
0.00%
-50.0%
Q2 2015$19,000
-87.2%
1,768
-83.5%
0.00%
-88.2%
Q1 2015$149,00010,6970.02%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,100,000$14,762,0006.34%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,882,805$52,107,0001.90%
Cheyne Capital Management (UK) LLP 326,821$4,388,0001.56%
BB BIOTECH AG 2,320,737$31,144,0001.27%
Broadfin Capital, LLC 854,384$11,466,0001.20%
HealthCor Management, L.P. 1,162,200$15,597,0000.80%
Orbimed Advisors 4,736,900$63,569,0000.66%
Rhenman & Partners Asset Management AB 148,000$1,986,0000.58%
SOUND ENERGY PARTNERS, INC. 51,000$684,0000.53%
Rock Springs Capital Management LP 210,000$2,818,0000.44%
View complete list of INFINITY PHARMACEUTICALS INC shareholders